These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7542505)

  • 1. Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity.
    Dybedal I; Jacobsen SE
    Blood; 1995 Aug; 86(3):949-57. PubMed ID: 7542505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood.
    Mizuguchi T; Kosaka M; Saito S
    Blood; 1993 Jun; 81(11):2891-7. PubMed ID: 8499628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
    Rusten LS; Dybedal I; Blomhoff HK; Blomhoff R; Smeland EB; Jacobsen SE
    Blood; 1996 Mar; 87(5):1728-36. PubMed ID: 8634418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
    Hassan HT; Biermann B; Zander AR
    Eur Cytokine Netw; 1996; 7(2):129-36. PubMed ID: 8688490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.
    Carow CE; Hangoc G; Cooper SH; Williams DE; Broxmeyer HE
    Blood; 1991 Nov; 78(9):2216-21. PubMed ID: 1718490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 is an inducer of erythroid differentiation.
    Krystal G; Lam V; Dragowska W; Takahashi C; Appel J; Gontier A; Jenkins A; Lam H; Quon L; Lansdorp P
    J Exp Med; 1994 Sep; 180(3):851-60. PubMed ID: 7520475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation.
    de Wolf JT; Muller EW; Hendriks DH; Halie RM; Vellenga E
    Blood; 1994 Jul; 84(1):59-64. PubMed ID: 7517219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro.
    Rusten LS; Lyman SD; Veiby OP; Jacobsen SE
    Blood; 1996 Feb; 87(4):1317-25. PubMed ID: 8608220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
    Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE
    Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
    Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
    J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1996 Feb; 166(2):305-10. PubMed ID: 8591990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.